跳至主要内容
临床试验/ACTRN12609000604202
ACTRN12609000604202已完成1 期

Randomized prospective study to compare the efficacy and safety of combined oral contraceptives plus spironolactone or cyproterone acetate for the treatment of hirsutism

Dr Sefa Kelekci0 个研究点目标入组 60 人开始时间: 2009年7月21日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
17 Years 至 35 Years(—)
性别
Female

入选标准

  • Nulligravid women with moderate-to-severe hirsutism, non-pregnant women or women who do not wish to become pregnant, no smoking, no history of breast cancer and endometrium cancer, no active liver disease, no history of thromboembolic disease, no treatment for hirsutism before.

排除标准

  • Subjects with thyroid disease, diabetes mellitus, adrenal disorders,
  • hyperprolactinemia, or any other disorder were excluded from the study. Women with hirsutism due to androgen excess such as late-onset congenital adrenal hyperplasia were not included in the study.

研究者

发起方
Dr Sefa Kelekci

相似试验